These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20528966)

  • 41. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heat shock proteins expression in canine intracutaneous cornifying epithelioma and squamous cell carcinoma.
    Romanucci M; Bongiovanni L; Marruchella G; Marà M; di Guardo G; Preziosi R; della Salda L
    Vet Dermatol; 2005 Apr; 16(2):108-16. PubMed ID: 15842541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of new immunohistochemistry scoring of p53 protein expression in cutaneous squamous cell carcinoma of mice.
    Bukhari MH; Niazi S; Anwar M; Chaudhry NA; Naeem S
    Ann N Y Acad Sci; 2008 Sep; 1138():1-9. PubMed ID: 18837875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
    Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE
    Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
    Kaufmann O; Fietze E; Mengs J; Dietel M
    Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Squamoid eccrine ductal carcinoma": an unusual low-grade case with follicular differentiation. Are these tumors squamoid variants of microcystic adnexal carcinoma?
    Kavand S; Cassarino DS
    Am J Dermatopathol; 2009 Dec; 31(8):849-52. PubMed ID: 19786851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
    Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
    Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
    Alexa A; Baderca F; Lighezan R; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2010; 51(1):27-35. PubMed ID: 20191116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
    Connolly M; Narayan S; Oxley J; de Berker DA
    Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung.
    Wang CW; Wu TI; Yu CT; Wu YC; Teng YH; Chin SY; Lai CH; Chen TC
    Am J Clin Pathol; 2009 May; 131(5):715-22. PubMed ID: 19369633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
    Schlauder SM; Calder KB; Moody P; Morgan MB
    Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 protein expression in cutaneous squamous cell carcinoma.
    Auepemkiate S; Boonyaphiphat P; Sriplung H
    J Med Assoc Thai; 2000 May; 83(5):543-8. PubMed ID: 10863901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin.
    Griffin JR; Wriston CC; Peters MS; Lehman JS
    Am J Clin Pathol; 2013 Apr; 139(4):442-7. PubMed ID: 23525614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.